BKYI — BIO-key International Share Price
0.000.00%
Last trade - 00:00- $2.98m
- $2.57m
- $7.75m
- 18
- 31
- 20
- 12
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.64 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.36 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1053.62% | ||
| Return on Equity | -307.2% | ||
| Operating Margin | -131% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.27 | 2.84 | 5.11 | 7.02 | 7.75 | 19 | n/a | 13.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company’s products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, AuthControl Sentry, AuthControl Enterprise, AuthControl MSP, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to provide a complete solution for its customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. Its WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration APIs.
Directors
- Michael DePasquale CHM (66)
- Kwok Fong Wong VCH (57)
- Cecilia Welch CFO (61)
- James Sullivan SVP (52)
- Mira LaCous CTO (58)
- Emmanuel Alia DRC (55)
- Thomas Bush IND (69)
- Thomas Gilley IND (61)
- Pieter Knook IND (63)
- Robert Michel IND (64)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- July 28th, 2004
- Public Since
- April 17th, 1997
- No. of Shareholders
- 159
- No. of Employees
- 43
- Sector
- Electronic Equipments & Parts
- Industry
- Technology
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 1,814,228
- Address
- 101 Crawfords Corner Rd, Suite 4116, HOLMDEL, 07733
- Web
- http://www.bio-key.com/
- Phone
- +1 7323591100
- Auditors
- Marcum LLP
Upcoming Events for BKYI
Q2 2024 BIO-Key International Inc Earnings Release
Q3 2024 BIO-Key International Inc Earnings Release
Similar to BKYI
Aeye
NASDAQ Capital Market
Akoustis Technologies
NASDAQ Capital Market
Alliance Entertainment Holding
NASDAQ Capital Market
Alpine 4 Holdings
NASDAQ Capital Market
Astrotech
NASDAQ Capital Market
FAQ
What is the BIO-key International share price?
As of Today at 19:38 UTC, shares in BIO-key International are trading at $1.37. This share price information is delayed by 15 minutes.
How has the BIO-key International share price performed this year?
Shares in BIO-key International last closed at $1.37 and the price had moved by -89.28% over the past 365 days. In terms of relative price strength the BIO-key International share price has underperformed the S&P500 Index by -91.47% over the past year.
What are the analyst and broker recommendations for BIO-key International?
The overall consensus recommendation for BIO-key International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the BIO-key International dividend yield?
BIO-key International does not currently pay a dividend.
Does BIO-key International pay a dividend?
BIO-key International does not currently pay a dividend.
When does BIO-key International next pay dividends?
BIO-key International does not currently pay a dividend.
How do I buy BIO-key International shares?
To buy shares in BIO-key International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BIO-key International?
As of the previous close price of $1.37, shares in BIO-key International had a market capitalisation of $2.49m.
Where are BIO-key International shares listed?
Here are the trading details for BIO-key International:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: BKYI
What kind of share is BIO-key International?
Based on an overall assessment of its quality, value and momentum BIO-key International is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BIO-key International share price forecast for 2024?
The analyst consensus target price for shares in BIO-key International is $18.00. That is 1213.87% above the last closing price of $1.37.
Analysts covering BIO-key International currently have a consensus Earnings Per Share (EPS) forecast of -$0.46 for the next financial year.
What is the trend in the BIO-key International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BIO-key International. Over the past six months, its share price has underperformed the S&P500 Index by -61.13%.
As of the last closing price of $1.37, shares in BIO-key International were trading -59.04% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BIO-key International PE Ratio?
The BIO-key International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BIO-key International?
BIO-key International's management team is headed by:
- Michael DePasquale - CHM
- Kwok Fong Wong - VCH
- Cecilia Welch - CFO
- James Sullivan - SVP
- Mira LaCous - CTO
- Emmanuel Alia - DRC
- Thomas Bush - IND
- Thomas Gilley - IND
- Pieter Knook - IND
- Robert Michel - IND